International Consensus Statement Published in Nature Reviews Nephrology Calls for Urgent Action to Address Chronic Kidney Disease on the Global Public Health Agenda

Nature Reviews Nephrology published a landmark international consensus statement titled “Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus.” Authored by a coalition of leading experts, stakeholders, and nephrology societies, the publication highlights critical policy, advocacy, and implementation needs to alleviate the growing burden of kidney disease worldwide.

American Society of Nephrology Celebrates Transformational Transplant Funding

Delivering on its commitment to increase Americans’ access to kidney transplant by improving the transparency and efficiency of our nation’s transplant network, Congress this week approved a much-needed $23 million federal funding increase in fiscal year (FY) 2024 for the Health Resources and Services Administration (HRSA), the agency responsible for overseeing the Organ Procurement and Transplantation Network (OPTN).

American Society of Nephrology and Home Dialysis University Expand Collaboration to Enhance Home Therapies Education for Nephrology Fellows

The American Society of Nephrology (ASN) and Home Dialysis University (HDU) launched a collaboration in 2023 to improve nephrology trainees’ knowledge, proficiency, and exposure to home dialysis therapies.

THE AMERICAN SOCIETY OF NEPHROLOGY APPALUDS THE INTRODUCTION OF THE HONOR OUR LIVING DONORS (HOLD) ACT, H.R. 6020

The American Society of Nephrology, representing 21,000 nephrologists, scientists and other kidney care professionals, today voiced its support for the Honor Our Living Donors (HOLD) Act (H.R. 6020), new legislation introduced by U.S. Representatives Jay Obernolte (R-CA-23) and Suzanne DelBene (D-WA-1) to qualify federal support for living organ donors based on donor income as opposed to current requirements that base support on the organ recipient’s income.

Hispanics Are Being Impacted By Diabetes and Kidney Disease

Paula Duran, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research impacting the Hispanic population. Why do Hispanics have a high incidence of diabetes and subsequent kidney disease? Is…

THE AMERICAN SOCIETY OF NEPHROLOGY CONGRATULATES HOUSE AND SENATE SPONSORS UPON ENACTMENT OF THE SECURING THE U.S. ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK

The American Society of Nephrology (ASN) congratulates the House and Senate sponsors of the Securing the U.S. Organ Procurement and Transplantation Network (OPTN) Act upon President Biden signing the legislation and thanks the Biden-Harris administration for its commitment to improving American’s access to transplantation.

Kidneycure Announces 2023 Grant Recipients

KidneyCure (the ASN Foundation) is honored to continue its support of investigators committed to advancing kidney health. Building on decades of success, KidneyCure makes it possible to improve knowledge and treatment by identifying and funding high-impact projects. Investigators funded by KidneyCure are making a difference in key areas that impact care for millions. KidneyCure is proud to support excellence and innovation, and to extend the advances that the foundation has propelled since its inception.

THE AMERICAN SOCIETY OF NEPHROLOGY AND HHS ANNOUNCE WINNERS OF $9.2 MILLION ARTIFICIAL KIDNEY PRIZE PHASE 2 AT KIDNEYX SUMMIT

Today, the Kidney Innovation Accelerator (KidneyX), a public private partnership between the American Society of Nephrology (ASN) and the US Department of Health and Human Services (HHS) announced the eight winners of the Artificial Kidney Prize Phase 2 at the KidneyX Summit in Washington, DC. The competition recognized participants’ innovative approaches to developing a bioartificial kidney and was divided into two tracks with two Track 1 participants each receiving $1,600,000, and six Track 2 participants each receiving $1,000,000.

AMERICAN SOCIETY OF NEPHROLOGY ANNOUNCES LIFETIME AND MIDCAREER 2023 AWARD RECIPIENTS

Each year, ASN recognizes individuals who have demonstrated exceptional leadership and achievements in clinical care, education, and research through our lifetime achievement and midcareer awards. Above all, kidney professionals imbue their work with compassion, dedication, and respect for the people whose lives they improve.

AMERICAN SOCIETY OF NEPHROLOGY NAMES RAJNISH MEHROTRA EDITOR-IN-CHIEF OF JASN AND SENIOR EDITOR-IN-CHIEF FOR THE ASN JOURNAL PORTFOLIO

The American Society of Nephrology (ASN) announced today that Rajnish Mehrotra, MD, MS, FASN, will be its new Editor-in-Chief of the Journal of the American Society of Nephrology (JASN) and Senior Editor-in-Chief for the ASN Journal Portfolio. Mehrotra’s term will begin January 1, 2024, and continue through December 31, 2029. He currently serves as the Editor-in-Chief of CJASN. The ASN Journal Portfolio includes three monthly journals, JASN, CJASN, and the online-only, open access journal, Kidney360.

American Society of Nephrology Statement on Introduction of the Securing the U.S. Organ Procurement and Transplantation Network Act

The American Society of Nephrology (ASN) applauds the introduction of the Securing the U.S. Organ Procurement and Transplantation Network Act, bipartisan legislation to ensure accountability and transparency in the U.S. transplant system by modernizing its underlying technology and policy infrastructure.

American Society of Nephrology and American Association of Kidney Patients Call on Congress to Increase Funding for Kidney Innovation and Veterans with Kidney Diseases

The prevalence of kidney diseases in the United States is at a record high. Today, more than 50 advocates from ASN and AAKP, representing people with kidney diseases and the health care professionals who serve them, will meet with their members of Congress and call for a $25 million investment in kidney innovation at KidneyX and support of veteran active duty service members living with or at risk of kidney diseases through the U.S. Department of Veterans Affairs (VHA) Kidney Health Program and the U.S. Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP).

American Society of Nephrology Statement on the United Network for Organ Sharing Clarifying Promise to Living Donors

The American Society of Nephrology (ASN) is grateful that the United Network for Organ Sharing (UNOS) has responded to urgent requests from living donors, patients, their families, and ASN, to commit to honoring promises to living donors in its forthcoming new kidney allocation system.

American Society of Nephrology Statement on U.S. Preventive Services Task Force Draft Research Plan on Screening for Kidney Diseases

The American Society of Nephrology (ASN) is encouraged by the recent U.S. Preventive Services Task Force (USPSTF) announcement to solicit comment on USPSTF’s draft research plan on screening for kidney diseases. This development follows more than a decade of advocacy in support of more kidney health screening by ASN and other stakeholders dedicated to intervening earlier to slow or stop the progression of kidney diseases.

Kidneycure Grant Applications Now Open to Support Investigators Committed to Advancing Kidney Health

KidneyCure, the grants program supported by the American Society of Nephrology (ASN) Foundation, today announced that applications for its 2023 grants programs are now open. KidneyCure grants support clinical and basic research and kidney health investigators at key professional development milestones. The submission deadline is Wednesday, December 7, 2022, at 2:00 p.m. EST. Grant applications and guidelines can be found at https://www.kidneycure.org/

KIDNEY WEEK 2022—THE WORLD’S PREMIER KIDNEY MEETING—TO CONNECT PEOPLE FROM ACROSS THE GLOBE

The American Society of Nephrology (ASN) will hold Kidney Week, the world’s premier kidney meeting, in Orlando, FL, November 3–6, 2022. The results of scientific studies and high-impact clinical trials that will advance kidney-related research and medical care will be presented in-person and online.

AMERICAN SOCIETY OF NEPHROLOGY (ASN) COMMITS $2,700,000 TO ITS NEW LOAN MITIGATION PILOT PROGRAM FOCUSED ON BUILDING EXCELLENCE IN NEPHROLOGY

• The five-year innovative pilot program offers financial support for trainees entering the field of nephrology, focusing on individuals historically underrepresented in medicine.
• Six candidates selected in the first year of the program will each receive $50,000 over the course of three years toward the repayment of eligible student loans.

Advocates from ASN Urges Congress to Change the Status Quo in Kidney Health

• More than 37 million Americans live with kidney diseases.
• 800,000 Americans have kidney failure, a condition for which there is no cure.
• Kidney diseases disproportionately affect communities of color.
• COVID-19, especially deadly for people with kidney diseases, has highlighted the urgent need for change

AMERICAN SOCIETY OF NEPHROLOGY LEADS EFFORTS TO ADVANCE EQUITABLE DISTRIBUTION OF COVID-19 VACCINES TO DIALYSIS PATIENTS

Washington, DC (February 25, 2021) —The American Society of Nephrology (ASN) is spearheading efforts to secure direct federal allocation of COVID-19 vaccines to dialysis patients and frontline dialysis workers. This allocation would improve access for a vulnerable patient population, more than half of whom are Black, Hispanic, Asian, Native American, and Native Hawaiian or other Pacific Islanders (NHPIs).

KIDNEYCURE ANNOUNCES 2020 GRANT RECIPIENTS

• Kidney diseases affect more than 850 million people worldwide.

• KidneyCure continues to propel positive change in public health, once again funding more than $3 million to support research that changes lives.

• This year’s grant recipients, among the best and the brightest in the field, bring energy, innovation and expertise to areas undergoing rapid change: acute kidney injury and repair, home dialysis, and post-transplant care.

KIDNEY HEALTH INITIATIVE URGES INVESTIGATORS TO INCLUDE PEOPLE WITH KIDNEY DISEASES IN CLINICAL TRIALS FOR CORONAVIRUS 2019 (COVID-19) THERAPIES

People with kidney diseases are often excluded from clinical trials because of the complexity and high morbidity of kidney disease.

COVID-19 puts people with kidney diseases at a two to sixteen-fold increased risk of severe symptoms.

All investigators should include people with kidney diseases when developing vaccines, preventative therapies or treatments related to COVID-19.

AMERICAN SOCIETY OF NEPHROLOGY TRANSPLANT POLICY PRIORITIES AT CENTER OF BOLD NEW PROPOSED RULES

The US Department of Health and Human Services (HHS) today took bold steps in two proposed rules to increase the availability of organs for the 113,000 Americans waiting for a lifesaving organ transplant – 20 of whom die each day – and to strengthen support for Americans who choose to be living donors. Both proposed rules advance policy changes the American Society of Nephrology has long been advocating for and is strongly supportive of.

STATEMENT OF AMERICAN SOCIETY OF NEPHROLOGY PRESIDENT MARK E. ROSENBERG, MD, FASN, ON THE KIDNEY CARE CHOICES MODEL ASN welcomes “visionary approach for the future of kidney care.”

American Society of Nephrology President Mark E. Rosenberg, MD, FASN, has issued the following statement regarding the new Kidney Care Choices Model:

“The American Society of Nephrology (ASN) welcomes the introduction of the voluntary Kidney Care Choices (KCC) Model, and its four kidney care payment options, addressing key aspects of the Executive Order on Advancing American Kidney Health (AAKH). This voluntary model will be a true game changer and brings desperately needed, sweeping changes to care for people with kidney diseases. ASN has long advocated for key elements of this model, and I thank HHS Secretary Azar and his entire team for putting forward such a visionary approach for the future of kidney care.

KIDNEYX INTRODUCES STEERING COMMITTEE

The U.S. Department of Health and Human Services (HHS) Office of the Chief Technology Officer and the American Society of Nephrology (ASN) today introduced the members of the newly formed KidneyX Innovation Accelerator (KidneyX) steering committee. This diverse group of experts will play a critical role in advancing the KidneyX mission to improve the lives of the 850,000,000 people worldwide currently affected by kidney diseases by accelerating innovation in kidney disease prevention, diagnostics, and treatment.